Abstract: It is of vital importance to find genetic variants that underlie human complex diseases and locate genes that are responsible for these diseases. Since proteins are typically composed of several structural domains, it is reasonable to assume that harmful genetic variants may alter structures of protein domains, affect functions of proteins and eventually cause disorders. With this understanding, the authors explore the possibility of recovering associations between protein domains and complex diseases. The authors define associations between protein domains and disease families on the basis of associations between non-synonymous single nucleotide polymorphisms (nsSNPs) and complex diseases, similarities between diseases, and relations between proteins and domains. Based on a domain -domain interaction network, the authors propose a 'guilt-by-proximity' principle to rank candidate domains according to their average distance to a set of seed domains in the domain-domain interaction network. The authors validate the method through large-scale cross-validation experiments on simulated linkage intervals, random controls and the whole genome. Results show that areas under receiver operating characteristic curves (AUC scores) can be as high as 77.90%, and the mean rank ratios can be as low as 21.82%. The authors further offer a freely accessible web interface for a genome-wide landscape of associations between domains and disease families.
Introduction
Modern human and medical genetics have been revolutionising biomedical studies with applications of genetic mapping techniques such as linkage analysis and association studies to the search for genetic variants underlying human complex diseases [1, 2] . With genetic regions being roughly identified by these techniques, it becomes vital to further locate genes that are responsible for complex diseases, for the purpose of facilitating the prevention, diagnosis and treatment of these diseases.
Typically, the problem of predicting genes underlying complex diseases is formulated as a prioritisation problem, in which one targets on scoring candidate genes and then ranking them according to their scores. This can be done via a 'guilt-by-association' principle, which relies on the assumption that a disease is likely to be caused by a set of genes that have similar properties [3] . With the use of this principle, one collects a set of well-defined seed genes, calculates the distance of every candidate gene to the seed genes and then ranks the candidate genes according to the scores [4, 5] . Here, the similarity measure can be the sequence similarity between genes, co-expression of genes across many conditions, the distance between gene products in protein-protein interaction networks and many others [4, 5] .
Many gene products (proteins) consist of several structural domains, each of which is closely related to a specific function of the proteins. It is therefore reasonable to assume that harmful genetic variants such as non-synonymous single nucleotide polymorphisms (nsSNPs) that are responsible for a complex disease may actually change structures of protein domains, affect functions of proteins and finally result in the disease. With this understanding, it becomes reasonable to pursue the goal of recovering associations between protein domains and complex diseases.
In this paper, we offer a proof-of-concept study for this problem with the use of a 'guilt-by-proximity' principle that is based on domain -domain interaction networks. We restrict complex diseases to a set of disease families [5] , and we compile a set of known associations between protein domains and the disease families with the use of protein family data in the Pfam database [6] and nsSNP data in the Swiss-Prot database [7] . We further collect a large-scale domain -domain interaction dataset DOMINE [8] and obtain a domain -domain interaction network. With these data ready, we propose the use of five distance measures, that is, direct neighbour (DN), shortest path (SP), SP with the Laplacian (SL) kernel, SP with the Gaussian (SG) kernel and diffusion kernel (DK), to calculate the distance between a candidate domain and the set of domains that are known to be associated with a disease family (seed domains). Finally, we use the distance scores to rank candidate domains.
We validate the above approach using large-scale crossvalidation experiments on simulated linkage intervals, random controls and the whole genome, and we evaluate the performance of the approach in terms of AUC score and mean rank ratio of domains that are known to be associated with the disease families. Results show that our approach can successfully recover the association between domains and disease families. We further provide a genome-wide landscape of the associations between protein domains and human disease families and offer a freely accessible web interface for this landscape.
Materials and methods

Data sources
2.1.1 Domain-disease associations: Associations between diseases and domains are defined on the basis of associations between diseases and nsSNPs, similarities between diseases, and relations between proteins and domains.
Associations between diseases and nsSNPs are obtained from the Swiss-Prot database [7] , in which nsSNPs are classified into three categories: disease, polymorphism and unclassified. For an nsSNP belonging to the disease category, the specific disease with which the nsSNP is associated is further annotated. In version 57.3 of this database (released on 26 May 2009), 22 069 nsSNPs are associated with diseases, and 32 695 belong to the polymorphism category. The rest 2113 nsSNPs are currently unclassified. Diseases in the above associations are entries in the Online Mendelian Inheritance in Man (OMIM) database [9] . Because OMIM collects a large number of human diseases, and many of them have similar characteristics, Köhler et al. [5] further studied similarities between diseases based on entries in OMIM and classified them into 110 disease families for genetically heterogeneous disorders, cancer and complex disease with similar or even indistinguishable phenotypes. We make use of this classification in our work.
Relations between human proteins and domains are obtained from the Pfam database, a collection of protein domain families [6] . This database contains a manually curated, high-quality collection of domain families (Pfam-A) and a collection of predicted domain families (Pfam-B). In version 23.0 of the Pfam-A collection (released in July 2008), 10 340 domain families that cover more than 74% of known proteins are collected.
With the above data sources, we define that a domain is associated with a disease if the domain contains at least one nsSNP that is associated with the disease. With this definition, we collect from the Swiss-prot and the Pfam databases 1842 associations between 765 domains and 1318 diseases. We further apply the criteria proposed by Köhler et al. [5] to these diseases and collected 92 disease families. Finally, we group the associations between domains and diseases and collect 398 associations between 239 domains and the 92 disease families.
Domain -domain interaction networks:
Protein domains are basic structural and functional units of proteins. Studies have shown that a majority of known proteins (2/3 in prokaryotes and 4/5 in eukaryotes) are composed of multiple domains [10] , and interactions between proteins often result from the binding of two or more domains [11] .
Protein-protein interactions can usually be identified via the use of high-throughput techniques such as yeast two hybrid assays [12, 13] and pull down mass spectrometry experiments [14, 15] , while specific domain -domain interactions are usually hard to detect and require much more efforts to analysis. Consequently, current large-scale domain -domain interaction data are mainly obtained from known protein -protein interactions through the use of computational methods. DOMINE is a database of known and predicted domain -domain interactions [8] .
A domain-domain interaction database can typically be encoded as a domain-domain interaction network, in which nodes are domains and undirected edges are interactions between domains. 3143 high-confidence interactions that are predicted using multiple sources of information or by at least two sufficiently different approaches, a set of 729 medium-confidence interactions in which both domains are annotated as belonging to the same gene ontology terms (biological process), and a set of 13 909 low-confidence interactions.
Guilt by proximity
Traditional approaches in the determination of genetic risk factors underlying complex diseases identify 10-30-Mb genetic regions using genome-wide statistical analysis methods, reduce the suspicious regions to about 1-Mb by a fine-mapping procedure and then perform functional tests to determine disease genes [1, 2] . To facilitate the localisation of such disease genes, several computational approaches have been developed [3, 5, 17, 18] . Since gene products (proteins) are typically composed of several structural and functional domains, it would be very helpful if some computational methods can also be incorporated to further locate which domains in the disease proteins are responsible for the diseases. With this understanding, we explore the possibility of recovering associations between protein domains and complex diseases with the use of the domain -domain interaction network.
Our objective is to predict novel associations between domains and disease families, using known domain -disease associations. Inspired by recent successes in the recovery of associations between diseases and suspicious genes with the use of protein-protein interaction networks [5, 19] , we use the domain -domain interaction network to facilitate the prediction.
The characteristic of this prediction task is that positive samples are quite limited, and negative samples are hard to define. For example, within the 10 340 domains collected in the Pfam database, only 13 of them are known to be associated with hypertrophic cardiomyopathy (CMH, MIM: 192 600). In other words, the number of positive samples is only 13, and the number of potential negative samples is more than 10 000. This situation is even worse for most of the other diseases. Actually, according to the datasets above, about 70% diseases are known to be associated with less than five domains according to our analysis. Considering these facts, we would not be able to formulate the prediction task as a typical binary classification problem. Instead, we formulate the task as a one-class prioritisation problem. More specifically, given a disease of interest, we use domains that are known to be associated with the disease as seed domains, and we calculate predictive scores for domains that need to be predicted (candidate domains). Then, we can rank the candidate domains according to their scores to obtain a ranking list, in which higher ranked domains are more likely to be associated with the disease.
The basic assumption in our prioritisation approach is that domains that are close in a domain -domain interaction network are likely to be associated with the same disease. On the basis of this notion, we use the average distance of a candidate domain to the set of seed domains as the predictive score. We call this principle 'guilt-by-proximity' and name the score 'proximity score'.
We propose the use of the following distance measures: (i) direct neighbour (DN), (ii) shortest path (SP), (iii) SP with Laplacian kernel (SL), (iv) SP with Gaussian kernel (SG) and (v) diffusion kernel (DK).
Given a domain -domain interaction network, the direct neighbour distance DN(i, j) between two domains i and j is defined as 1 if they have interaction and +1 otherwise.
The shortest path distance SP(i, j) between two domains i and j is defined as the length of the SP between the two domains. We further introduce two kernels to tune this distance measure. With the use of the Laplacian kernel, the distance measure
With the use of the Gaussian kernel, the distance measure
Note that both a and b are free parameters, and we set them to 1 in our studies.
, where 0 , g , 1 is a free parameter that controls the magnitude of diffusion. The matrix L ¼ D 2 A is the Laplacian of the network, where D is a diagonal matrix containing node degree, and A is the adjacent matrix of the network. With the kernel K, the diffusion kernel distance DK(i, j) between two domains i and j is defined as DK(i, j) ¼ k ij .
Using one of the above measures, the proximity score of a domain d is then calculated as the average distance between this domain and all seed domains. For example, the proximity score with the use of the DN measure is
where seed is the collection of seed domains. Note that when using the DN and the SP, candidate domains with smaller scores are more likely to be associated with the disease, while the opposite situations are held for the DK, the SL and the SG.
Validation method and evaluation criteria
Given the domain -domain interaction network and the known associations between domains and disease families, we would like to validate whether the proposed guiltyby-proximity approach is able to recover these associations. We adopt a large-scale leave-one-out cross-validation experiment for this purpose. We focus on disease families that are associated with two or more domains in the validation procedure, since we need to use at least one domain that is associated with a disease family as the seed to calculate the proximity score and one domain to validate the prioritisation performance. More specifically, in each validation run, we select an association between a domain and a disease family, assume that the domain is not associated with the disease family, and prioritise the domain against a control set of m domains. In this procedure, seed domains are selected as all domains that are associated with the disease family, except for the domain under investigation. Repeating this prioritisation procedure for every association, we are able to obtain a number of rank lists, each containing m + 1 candidate domains. We further normalise the ranks by dividing them with the total number of candidate domains (m + 1) to obtain rank ratios.
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With the rank ratios, we propose to use the following evaluation criteria. The Sensitivity is defined as the percentage of disease domains that are ranked above a threshold. The specificity is the percentage of random selected domains that are ranked below this threshold. In other words, sensitivity is the true positive rate, and the specificity is the true negative rate. Varying threshold values, we are able to plot a receiver operating characteristic (ROC) curve, which shows the relation between sensitivity and one minus specificity. Calculating the area under the ROC curve, we are able to obtain the AUC score, which provides an overall measure for the performance of the prioritisation method. Besides, we also use the mean rank ratio of all disease domains (the average of rank ratios of all disease domains) as another measure of the performance. We focus on diseases families that are associated with two or more domains in the validation, because the proposed approach requires at least one domain as the seed in the calculation of the proximity score. With this criterion, we filter out 27 diseases families that have only one associated domain and obtain 65 disease families that are associated with a total of 207 domains.
Results
Performance of the proposed approach
With the use of the leave-one-out cross-validation experiment, we test our method on three types of control sets: simulated linkage intervals, random controls and the whole genome. We prioritise each domain that is associated with a disease family against a control domain set with unknown associations. In this procedure, seed domains are selected as all domains that are associated with the disease family, except for the domain under investigation. From the rank ratio lists, we calculate an AUC score and a mean rank ratio of the disease domains.
To simulate the real situation in which one or more susceptible linkage intervals have been identified by linkage analysis or association studies, we define the simulated linkage interval for each domain associated with a disease family. Using Ensemble EBI [20] , we first locate the gene contain the nsSNP defining the association between disease family and domain. Then we collect the control set by choosing candidate domains in the domain -domain interaction network and locate in the 10 Mb upstream and downstream of this gene. For the domains belong to more than one gene causing the same disease, we generate the control set by taking the union. There are on average 53.8 candidate domains in the linkage intervals, where the minimum number of candidate domains in the linkage interval is 8, and the maximum is 263. Therefore we set a threshold of 50, and only make use of the linkage intervals containing more than 50 candidate domains. The ROC curve and the AUC score for the five scoring methods are shown in Fig. 1a , and their mean rank ratios are shown in Table 1 . Note that we vary the threshold from 20 to 60 with step 10 and found no significant differences in the results (data not shown).
We can see from these results that the DK method in general achieves the highest AUC score and the lowest mean rank ratio, and the DN method performs the worst. Methods on the basis of the SP typically perform better than the DN method but worse than the DK method. The difference between the Laplacian kernel and the Gaussian kernel is negligible, but both kernels perform slightly better than the original SP measure without a kernel transform.
The main reason that the DN method performs the worst might attribute to the fact that the DN measure only uses information of domains that are directly connected. In other words, this measure is a local one. On the contrary, the superior performance of the DK measure might result from the inherent global property in the calculation of the kernel, in which all available interactions are considered.
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Similarly, methods based on the SP use information of interactions in the paths, which contain more information than the DN method but contain less than the DK method, and thus these measures achieve a medium performance.
To verify this conjecture, we implement a new metric by only taking advantage of DK scores within the range of DNs. That is, if there is an interaction between two domains i and j, the distance between them is defined as DK(i, j), otherwise, the distance is defined as 0. We validate this new metric on the simulated linkage interval and obtain a mean rank ratio of 25.13 and an AUC of 0.7354. These results are worse than those of the original DK (mean rank ratio ¼ 21.82, AUC ¼ 0.7790) and almost the same as those of the DN (mean rank ratio ¼ 25.43, AUC ¼ 0.7379). Our conclusion is that if we only make use of the DK measure in the local range, we get similar results as the local measure. In other words, the inherent global property of the DK does help the improvement of the performance.
Another reason that may partly account for the poor performance of the DN method might be due to the fact that many candidate domains could have equal distances to a seed (remember there are only two possible distance scores 1 and +1 under the DN measure), and such ties are broken at random in our calculation. Therefore the method producing fewer ties is potentially more powerful than the one generating more ties. To see whether this conjecture is correct or not, we count the number of ties produced by each method at a certain rank threshold, divide this number by the total number of domains ranked above this threshold to obtain a normalise ratio of ties and compare this ratio. For a clear presentation, we define the discriminative power of a method at the rank threshold as 1 -this ratio. By varying the rank threshold, we can draw a curve of the discriminative power for a measure. The curve for a method that can produce fewer ties will locate above a method that tends to generate more ties.
The results for the simulated linkage interval are shown in Fig. 2 . We can see from this figure that the DK measure has the highest possible discriminative power, whereas the DN measure has the lowest power among all the methods compared. The SP measure has higher discriminative power than the DN measure, and both Gaussian and Laplacian kernel transforms are helpful in improving the discriminative power of the SP measure. We can also see that the two kernels, Gaussian and Laplacian, produce very similar results under all threshold values. We note that the discriminative power of a method is closely related to its We also note that the kernel transform of the SP measure will greatly reduce possible ties and thus lead to significant improvement in the performance. To further explore this observation, let us see the following example. Disease family Arthrogryposis associated with four domains: Myosin_head, Myosin_tail_1, Tropomyosin and Troponin. When we use Myosin_head to validate the methods, the SP measure ranks six domains at the top: Myosin_head, FKBP_C, Tektin, UCH, WW and Metallophos, whereas the SP with Gaussian kernel only ranks Myosin_head at the top. We check the SP scores of the six domains to the seed domains associated with Arthrogryposis except Myosin_head and find that the SP scores for Myosin_head are 1, 3 and 2, while for other five domains are 2, 2 and 2. As a result, if we use SP measure, the prediction score for the six domains are the same, but if we use the Gaussian kernel, Myosin_head can be discriminated from other five mainly because of the larger score resulting from the smaller distance. With this understanding, it is not hard to understand why kernel transforms could be helpful. Kernel transforms can amplify shorter distance in a nonlinear manner and thus give higher scores to candidates that are closer to one of the seeds.
Robustness of the proposed approach
In order to verify that the correct prioritising of disease domains relies on informative interactions between domains instead of random interactions, we shuffle interactions between domains while fixing the degree (number of DNs) of each domain, and we repeat the leave-one-out crossvalidation experiment with the use of the shuffled random network. Because a shuffled network contains no informative interactions between domains, it is expected that both mean rank ratio and the AUC score should be around 50%. The results on the simulated linkage intervals are shown in Fig. 1b and Table 1 . We can see from these results that with the shuffled network, the AUC scores are in general below 55%, and the mean rank ratios are above 45%. These results suggest that our method can utilise the information contained in the domain -domain interaction network to achieve a reasonable good recovery of domaindisease associations.
In order to evaluate the robustness of the methods, we conduct a leave-one-out cross-validation experiment on random controls. For each domain associated with the disease, a set of 99 domains are randomly selected from the domains with unknown associations in the domaindomain interaction network. We further repeat the crossvalidation experiment 100 times to obtain standard derivations of the AUC score and the mean rank ratio. The results are shown in Fig. 3a and Table 1 . In general, our approach achieves reasonable higher performance on the random controls than on the simulated linkage interval, and the small standard derivations of both the mean rank ratio and the AUC indicate that our methods are robust.
In order to validate the performance of our approach on the direct identification of disease domains, we perform a leaveone-out cross-validation experiment to simulate the genomewide scan of disease domains. In each validation run, we prioritise a disease domain that is associated with a disease family against all domains with unknown associations. In this procedure, seed domains are also selected as all domains that are associated with the disease family, except for the domain under investigation. The results in Fig. 3b and Table 1 show that AUC score is 0.8790, and the mean rank ratio for disease domains is 11.77 (DK method, DOMINE dataset with all interactions). In other words, our approach is capable of identifying the disease domain from all domains that spread over the whole genome.
In order to check the impact of criterion for determining domain-domain interactions, we repeat the leave-one-out cross-validation experiment with the use of only high confident interactions that are derived from PDB entries or predicted by two or more computational approaches in DOMINE. The giant component of this high confident dataset contains 4348 interactions between 1628 domains, 154 of them are associated with 57 disease families which are associated with more than two domains. The mean rank ratios for DK, SP, SL, SG and DN are 20.13, 20.23, 20.18, 20.19 and 27.14, respectively. The ROC curves and AUC scores are given in Fig. 4a . These results show that the high confident domain-domain interaction data could lead to slightly higher performance for all methods except for the DN measure.
It might be argued that the domain -domain interaction network we used might be biased towards disease domains. An examination of the high confident part of the DOMINE shows that indeed disease domains have more direct interaction partners than non-disease domains (9.54 against 3.48). However, it is difficult to show conclusively whether this bias is due to the preferential interest of investigators in disease-related domains, or the intrinsic property of disease domains. Nonetheless, to assess whether our methods critically relies on this bias, we construct a unbiased network in which degrees of disease and nondisease domains are comparable by starting from high confident interactions, fixing node degrees of disease domains and adding from the DOMINE dataset mediumor low-confidence interactions between non-disease domains. We then repeat the leave-one-out cross-validation experiment with the use of this unbiased network. The ROC curves and AUC scores are given in Fig. 4b . These results show that our approach could still achieve reasonable good performance with this unbiased network, although the AUC scores for most measures drop slightly. In other words, although the current domain -domain interaction network might be biased towards disease domains, our approach does not rely on such bias to recover the associations between disease families and domains.
Landscape of domain -disease associations
The above validation results demonstrate the possibility of recovering the association between domains and disease families, with the use of the 'guilt-by-proximity' principle.
Here we provide a genome-wide landscape of the associations between protein domains and human disease families. For every disease family, we prioritise all domains with unknown associations with the use of the DK measure. In this procedure, seed domains are selected as all domains that are known to be associated with the disease family. The prioritisation results, together with a freely accessible web interface, are provided at http://bioinfo.au. tsinghua.edu.cn/domain. As illustrations, we give below some examples of this landscape.
In the first example, we predict that a Zinc finger domain, C4 type (zf-C4, Pfam: PF00105), in the protein of Hepatocyte nuclear factor 4A (HNF4A, MIM: 600281) is likely to be linked to the disease of maturity-onset diabetes of the young (MIM: 606391). This domain ranks the 10th out of a total of 3077 domains with the use of Domine interaction data. HNF4A is a tissue-specific transcription factor that plays an essential role in the early vertebrate development and embryonic survival. It regulates the expression of a wide variety of essential genes, including those involved in liver and pancreatic cell differentiation [21] , embryogenesis and early development [22] , glucose metabolism [23] , as well as lipid homeostasis [24] and amino-acid metabolism [25] . Mutations in HNF4A cause a dominantly inherited form of diabetes known as maturity-onset diabetes of the young (MODY) [26] . These mutations cause the loss of function of the gene product [22] , which leads to impaired insulin secretion and defects in metabolic pathways [27] . HNF4A consists of distinctive functional domains including a DNA-binding domain (DBD), a ligand-binding domain (LBD) and additional domains with transcription-activation functions [25] . The DBD in HNF4A is zf-C4, which contains two zinc-finger motifs that specifically recognise and bind as a homodimer to a direct repeat of two hexameric half-sites separated by one (DR1, in the majority) or two nucleotides (DR2) [28, 29] . Five MODY1 missense mutations (on four different residues) are found within the region of zf-C4 [30] .
In the second example, we predict the high rank of association with Alzheimer's disease (MIM: 104300) for Amyloid A4 extracellular domain (A4_EXTRA, Pfam: PF02177) and Kunitz/Bovine pancreatic trypsin inhibitor domain (Kunitz_BPTI, Pfam: PF00014) in Amyloid beta A4 precursor protein (A4, MIM: 104760). A4_EXTRA ranks the second out of 3083 domains in Domine. Kunitz_BPTI ranks the first out of 3083 domains in Domine. Amyloid beta A4 precursor protein is cut by enzymes to create smaller fragments (peptides), some of which are released outside the cell. Amyloid beta peptide is one of these fragments which is found the major molecular component of neuritic plaque [31] . The neuritic plaque is identified, by Alzheimer, abnormal deposition in the brain of patients of Alzheimer's disease [32] . Approximately 20 different mutations in Amyloid beta A4 precursor protein cause type 1 Alzheimer disease. These mutations are responsible for about 10 -15% of all early-onset familial Alzheimer disease cases [33] . According to Alzheimer Disease & Frontotemporal Dementia Mutation Database (http://www.molgen.ua.ac.be/ADMutations), we find that most of the mutations are located in the beta-amyloid peptide (beta-APP), which is reported to contain a nsSNP causing Alzheimer's disease, and none located in A4_EXTRA and Kunitz_BPTI. In the brain, there are three major isoforms of APP, the shortest of which lacks Kunitz_BPTI domain [34] . The biological relevance of these different isoforms remains unknown but the findings of elevated levels of Kunitz_BPTI domain may somehow facilitate Amyloid beta peptide deposition [35, 36] .
In the third example, the PWWP domain (Pfam: PF00855) in MutS homolog 6 (MSH6, MIM: 600678) is predicted with high rank of association with hereditary non-polyposis colorectal cancer (HNPCC, MIM: 120435). It ranks the first out of 3076 domains in Domine. Hereditary non-polyposis colorectal cancer is caused by germline mutations in DNA mismatch repair genes. The majority of cases are associated with mutations in MutS homolog 2 (MSH2, MIM: 609309) or MutL homolog 1 (MLH1, MIM: 120436). However, about 12% of cases are associated with alterations in MSH6. The MSH6 protein forms a heterodimer with MSH2 that is capable of recognising a DNA mismatch. The heterodimer then utilises its adenosine nucleotide processing ability in an, as of yet, unclear mechanism to facilitate communication between the mismatch and a distant strand discrimination site [37] . The S144I mutation, lies in PWWP, was identified in the germline of three non-related cancer families but in none of 400 control individuals tested providing strong genetic evidence that this variant is significant for the disease [38 -40] . S144I may have a role in downstream protein -protein interactions or mismatch repair genes regulation as Ser-144 has been detected as a phosphorylation site [41] .
Discussion
In this paper, we define associations between protein domains and disease families with the use of (i) associations between nsSNPs and complex diseases, (ii) similarities between diseases and (iii) relationships between proteins and domains. We collect 1842 associations between 765 domains and 1318 diseases and further group these associations to a set of 398 associations between 239 domains and 92 disease families.
Based on domain -domain interaction networks, we put forward a 'guilt-by-proximity' principle and adopt five proximity scores to facilitate the recovery of associations between candidate domains and disease families. We adopt large-scale cross-validation experiments on simulated linkage interval, random control and the whole genome to validate our method. Results show that our approach can successfully prioritise domains that are known to be associated with disease families on the top of the resulting ranking lists. We further provide a genome-wide landscape of associations between protein domains and disease families and present several examples. This landscape can be potentially used with existing methods for determining disease genes, and providing useful information in the localisation of genetic risk factors underlying complex diseases.
The success of our approach can mainly be attributed to the principle of 'guilt-by-proximity,' which has been widely used in the inference of disease genes underlying complex diseases [3, 5, 17, 18] . In our studies, we find that this principle is quite robust to the noises existing in domaindomain interaction networks. Certainly, besides domaindomain interaction networks, one can also pursue the incorporation of other information such as sequence or structure similarities between domains into our approach.
The proposed analysis of domains could potentially benefit the study of complex diseases from the following aspects. First, besides widely accepted concepts of SNP-disease associations and gene -disease associations, we introduce the concept of associations between protein domains and complex diseases, and we validate the possibility of recovering such associations with the use of domaindomain interaction networks. This concept might offer researchers a new perspective to explore the genetic pathogenesis of complex disease. Second, although current sequencing and re-sequencing techniques make it possible to sequence large genetic regions, it is still costly and time consuming. In such a case, a domain recognised as associated with a disease could greatly reduce the search regions for true causative genetic variants. Third, a domain identified as associated with a disease could indicate explicitly the possible change of protein functions, thereby offering helpful information to facilitate the understanding of the pathogenesis of the disease.
Certainly, our approach might be extended from the following directions. First, our approach currently uses associations between nsSNPs and complex diseases to bridge associations between protein domains and disease families. Alternatively, one can also pursue the inference of the associations between protein domains and disease families with the use of known associations between genes and diseases. Existing research on predicting domaindomain interactions from protein -protein interactions can provide some clues in this direction. Second, although the proposed approach is validated using disease families, it is not hard to extend this method for predicting associations between domains and diseases in the OMIM database, as long as a disease is known to be associated with at least one domain. Third, our approach requires a set of seed domains, which are currently quite limited. Recent studies have suggested pair-wise similarities between many diseases [42] . With the use of these similarities, methods have also been developed to predict diseases genes for complex diseases with unknown seeds [19] . How to incorporate this similarity information into our approach remains a future research topic.
